Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Influenza Vaccines - Pipeline Assessment and Market Forecasts to' returned 19 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Microneedle Drug Delivery: Technology, Devices, Players, Markets & Prospects   Greystone Associates, May 2011 of microneedle drug delivery devices such as the sanofi-aventis Intanza influenza vaccine, which is based on the Becton Dickinson Soluvia syringe-mounted microneedle array device, is a milestone in the transition 2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 976 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38 2012 Italy Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 970 Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background - HIV-6 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses 2012 Global Influenza Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country   Venture Planning Group, April 2012, Pages: 232 2012 Global Influenza Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country The report presents a detailed analysis of the Influenza diagnostics market in the US 2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 980 35. Human Herpes Virus-6 (HHV-6) a. Background -- HIV-6 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella Global Microbiology Testing Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers   Venture Planning Group, June 2011, Pages: 1900 and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38. Lyme Disease a. Background 0 Clinical 2012 Germany Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 983 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38 2012 Spain Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 960 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38 2012 Global Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 1900 -6 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines Future US Microbiology Testing Market Outlook   Venture Planning Group, Feb 2012, Pages: 1037 Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs 35. Human Herpes Virus-6 (HHV-6) a. Background 0 HIV-6 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses The 2011 German Infectious Disease Testing Market   Venture Planning Group, April 2010, Pages: 983 . Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38. Lyme Disease a. Background - Clinical Description Avian Influenza   TriMark Publications, Aug 2006, Pages: 139 market. An analysis of the technology trends and developing areas of influenza infection science is provided, along with a review of the market for pharmaceutical agents, vaccines and hospital supplies in clinical use 2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies   Venture Planning Group, April 2012, Pages: 978 Infections b. Diagnostic Tests c. Vaccines and Drugs 36. Influenza Viruses a. Background b. Diagnostic Tests c. Vaccines and Drugs 37. Legionella a. Background b. Diagnostic Tests c. Vaccines and Drugs 38 Bioinformatics for Vaccinology   John Wiley and Sons Ltd, Nov 2008, Pages: 312 of Disease Lifespans The Evolving Nature of Disease Economics, Climate, and Disease Three Threats Tuberculosis in the 21st Century HIV and AIDS Malaria: Then and Now Influenza Bioterrorism Vaccines Neuroprotection - Drugs, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 633 it will constitute a major and important component of the CNS market. Forecasts are made until 2021. By that time neuroprotection will be an established part of the neurological practice and measures will be available Molecular Diagnostics - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 1037 to technologies, applications and geographical regions. Forecasts are made up to 2021. A major portion of the molecular diagnostic market can be attributed to advances in genomics and proteomics. Biochip Vitamins and Dietary Supplements in Kazakhstan   Euromonitor International, April 2012, Pages: 32 and identify factors driving change; - Understand the competitive environment, the market’s major players and leading brands; - Use five-year forecasts to assess how the market is predicted to develop Tissues in Poland   Euromonitor International, April 2010, Pages: 29 Tissues in Poland In 2009 the issue of swine flu, A/H1N1 virus and vaccines against influenza dominated media. The number of cases of falling ill from swine flu was fewer than seasonal influenza Global Medical Tourism   TriMark Publications, Dec 2008, Pages: 291 -Diphtheria Vaccine 275 Appendix 6.3.10: Varicella Vaccine 275 Appendix 6.3.11: Influenza and Pneumococcal Vaccines 275 Appendix 6.3.12: Hepatitis A Vaccine and Immune Globulin 276 Appendix 6.3.13: Typhoid Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network